Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinwei capsule in nonalcoholic steatohepatitis (dose–response, phase II)
CTR20240691Phase 2Active
- Sponsor
- Sichuan Academy of Chinese Medical Sciences
- Start
- Mar 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Qinwei Jiaonang in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Sichuan Academy of Chinese Medical Sciences. Started Mar 2024; status: active.
02
Drugs
Qinwei Jiaonang
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on CTR20240691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240691.